Differential activation of IFN regulatory factor (IRF)-3 and IRF-5 transcription factors during viral infection.

TitleDifferential activation of IFN regulatory factor (IRF)-3 and IRF-5 transcription factors during viral infection.
Publication TypeJournal Article
Year of Publication2006
AuthorsCheng T-F, Brzostek S, Ando O, Van Scoy S, K Kumar P, Reich NC
JournalJ Immunol
Volume176
Issue12
Pagination7462-70
Date Published2006 Jun 15
ISSN0022-1767
KeywordsAmino Acid Sequence, Animals, Apoptosis, Cell Line, Tumor, CREB-Binding Protein, Dimerization, E1A-Associated p300 Protein, Gene Expression Regulation, HeLa Cells, Humans, Interferon Regulatory Factor-3, Interferon Regulatory Factors, Interferon-gamma, Mice, Mice, Knockout, Molecular Sequence Data, Mutagenesis, Site-Directed, Newcastle disease virus, Nuclear Proteins, p300-CBP Transcription Factors, Protein Binding, Regulatory Sequences, Nucleic Acid
Abstract

Members of the IFN regulatory factor (IRF) family regulate gene expression critical to immune response, hemopoiesis, and proliferation. Although related by homology at their N-terminal DNA-binding domain, they display individual functional properties. The distinct properties result from differences in regulated expression, response to activating signals, and interaction with DNA regulatory elements. IRF-3 is expressed ubiquitously and is activated by serine phosphorylation in response to viral infection or TLR signaling. Evidence indicates that the kinases TANK-binding kinase 1 and inhibitor of NF-kappaB kinase-epsilon specifically phosphorylate and thereby activate IRF-3. We evaluated the contribution of another member of the IRF family, IRF-5, during viral infection since prior studies provided varied results. Analysis of phosphorylation, nuclear translocation, dimerization, binding to CREB-binding protein, recognition of DNA, and induction of gene expression were used comparatively with IRF-3 as a measure of IRF-5 activation. IRF-5 was not activated by viral infection; however, expression of TANK-binding kinase 1 or inhibitor of NF-kappaB kinase-epsilon did provide clear activation of IRF-5. IRF-5 is therefore distinct in its activation profile from IRF-3. However, similar to the biological effects of IRF-3 activation, a constitutively active mutation of IRF-5 promoted apoptosis. The apoptosis was inhibited by expression of Bcl-x(L) but not a dominant-negative mutation of the Fas-associated death domain. These studies support the distinct activation profiles of IRF-3 in comparison to IRF-5, but reveal a potential shared biological effect.

DOI10.4049/jimmunol.176.12.7462
Alternate JournalJ Immunol
PubMed ID16751392
Grant ListP01AI0555621 / AI / NIAID NIH HHS / United States
P01CA2814 / CA / NCI NIH HHS / United States
Related Faculty: 
Sabrina Racine-Brzostek, M.D., Ph.D.

Pathology & Laboratory Medicine 1300 York Avenue New York, NY 10065 Phone: (212) 746-6464
Surgical Pathology: (212) 746-2700